An essential role for Daxx in the inhibition of B lymphopoiesis by type I interferons

Immunity

Volumn 14, Issue 6, 2001, Pages 727-737

  Gongora, Rafael ^a,d   Stephan, Robert P ^a   Zhang, Zhixin ^a   Cooper, Max D ^a,b,c,d  

^a University of Alabama at Birmingham   (United States)

^b University of Alabama at Birmingham   (United States)

^c University of Alabama at Birmingham   (United States)

^d HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; AMIDE; ANTISENSE OLIGONUCLEOTIDE; BENZYLOXYVALYLALANYLASPARTYLFLUOROMETHYL KETONE; BETA INTERFERON; CASPASE INHIBITOR; CYCLOHEXAMIDE; DAXX PROTEIN; DEXAMETHASONE; FAS ANTIGEN; INTERLEUKIN 7; KETONE; PROTEIN BCL 2; STAT1 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CELL CYCLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL DIFFERENTIATION; CELL GROWTH; CELL LINE; CELL SURVIVAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; FETUS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REPRESSION; GENE TRANSLOCATION; GROWTH DISORDER; LYMPHOPOIESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL; T LYMPHOCYTE;

EID: 0034948684     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(01)00152-2     Document Type: Article

References (59)

1. The s-Myc protein having the ability to induce apoptosis is selectively expressed in rat embryo chondrocytes
2. Identification of a novel nuclear domain
3. B cell development: Signal transduction by antigen receptors and their surrogates
4. Promyelocytic leukemia (PML) nuclear bodies are protein structures that do not accumulate RNA
5. Bcl-2 confers growth and survival advantage to interleukin 7-dependent early pre-B cells which become factor independent by a multistep process in culture
6. Genetics basis of abnormal B cell development
7. Stats and gene regulation
8. Centromeric proteins recognized by CREST sera and meiotic chromosome segregation
9. Targeted disruption of the mouse Stat-1 gene results in compromised innate immunity to viral disease
10. A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein
11. A dynamic connection between centromeres and ND10 proteins
12. Interleukin-7 can induce the activation of Jak1, Jak3 and STAT5 proteins in murine cells
13. Molecular cloning of a new interferon-induced PML nuclear body-associated protein
14. Stat-1 is not essential for inhibition of B lymphopoiesis by type I interferons
15. A unique ISRE, in the TATA-less human Isg20 promoter, confers IRF-1 mediated responsiveness to both interferon type I and type II
16. Caspase-mediated activation and induction of apoptosis by the mammalian Ste20-like kinase Mst1
17. Apoptotic pathways: Paper wraps stone blunt scissors
18. Interferon-modulated expression of genes encoding the nuclear-dot-associated proteins Sp100 and promyelocytic leukemia protein (PML)
19. IFN enhanced expression of Sp100, an autoantigen in primary biliary cirrhosis
20. Signal transduction in the interferon signal
21. Inhibition of interleukin 1beta converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage
22. Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow
23. Life, death and nuclear spots
24. The Pax3-FKHR oncoprotein is unresponsive to the Pax3-associated repressor hDaxx
25. Chromosomal translocation t(15:17) in human acute promyelocytic leukemia fuses RARα with a novel putative transcription factor, PML
26. The protein encoded by the VpreB and λ5 pre-B specific genes can associate with each other and with μ heavy chain
27. B lymphopoiesis: Global factors, local control
28. CpG motifs in bacterial DNA trigger direct B-cell activation
29. Localization of nascent RNA and CREB binding protein with the PML-containing nuclear body
30. Sequestration and inhibition of Daxx-mediated transcriptional repression by PML
31. EAP1/Daxx interacts with ETS1 and represses transcriptional activation of ETS1 target genes
32. Impairment of T and B cell development by treatment with a type I interferon
33. Jak/Stat signaling by cytokine receptors
34. Fas receptor expression on B-lineage cells
35. Antibody regulation of B cell development
36. Targeted disruption of the Stat-1 gene in mice reveals unexpected physiologic specificity in the Jak-Stat signaling pathway
37. Loss of Daxx, a promiscuously interacting protein, results in extensive apoptosis in early mouse development
38. Stimulation of B-cell progenitors by cloned murine interleukin-7
39. Stepwise progression of B cell malignancy occurred in a bone marrow stromal cell-dependent pre-B cell clone
40. The structure, regulation and function of the Janus kinases (Jaks) and the signal transducers and activators of transcription (Stats)
41. Early lymphocyte expansion is severely impaired in interleukin-7 receptor-deficient mice
42. Signaling pathways activated by interferons
43. Triple helix formation and the antigene strategy for sequence-specific control of gene expression
44. Tyrosine-phosphorylated Stat1 and Stat2 plus a 48-kDa protein all contact DNA in forming interferon-stimulated-gene factor 3
45. Clonal selection and learning in the antibody system
46. Transcriptional induction of the PML growth suppressor gene by interferons is mediated through an ISRE and a GAS element
47. Inhibition of B cell receptor-mediated apoptosis by IFN
48. - thymocytes
49. Human Daxx regulates Fas-induced apoptosis from nuclear PML oncogenic domains (PODs)
50. Type I IFN sets the stringency of B cell repertoire selection in the bone marrow
51. A novel assay for apoptosis. Flow cytometric detection of phosphatydyl serine expression on early apoptotic cells using fluorescein labeled AnnexinV
52. Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a non redundant cytokine
53. Resident bone marrow macrophages produce type I interferons that can selectively inhibit interleukin-7 driven growth of B lineage cells
54. PML is essential for multiple apoptotic pathways
55. Role of PML in cell growth and the retinoic acid pathway
56. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis
57. Daxx, a novel Fas-binding protein that activates JNK and apoptosis
58. Promyelocytic leukemia protein (PML) and Daxx participate in a novel nuclear pathway for apoptosis